Here is how Altria (MO) and Ambev (ABEV) have performed compared to their sector so far this year.
Altria Group, Inc. reported a solid Q3 2025 with adjusted EPS up 5% and strong free cash flow. MO stock nevertheless dropped 7% in reaction to the report. MO's core cigarette business remains highly profitable, with margin expansion and continued dominance in the premium segment, but faces retail share pressure from downtrading. Disappointing Q3 performance in the oral nicotine segment, especially on! pouches, raises concerns.
Altria Group, Inc. ( MO ) Q3 2025 Earnings Call October 30, 2025 9:00 AM EDT Company Participants Mac Livingston - Vice President of Investor Relations William Gifford - CEO & Director Salvatore Mancuso - Executive VP & CFO Conference Call Participants Matthew Smith - Stifel, Nicolaus & Company, Incorporated, Research Division Bonnie Herzog - Goldman Sachs Group, Inc., Research Division Eric Serotta - Morgan Stanley, Research Division Mirza Faham Baig - UBS Investment Bank, Research Division Presentation Operator Good day, and welcome to the Altria Group 2025 Third Quarter and 9 Months Earnings Conference Call. Today's call is scheduled to last about 1 hour, including remarks by Altria's management and a question-and-answer session.
MO's third-quarter profit tops expectations on higher pricing and cost savings, even as cigarette and oral tobacco sales slip.
While the top- and bottom-line numbers for Altria (MO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Altria reported mixed Q3 financials, beating on earnings but missing on revenue.
Altria (MO) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings of $1.38 per share a year ago.
Tobacco giant Altria forecast annual profit largely below market expectations on Thursday, hurt by lower demand for its cigarettes and oral smoking alternatives such as on! nicotine pouches.
Altria's pricing power, smoke-free gains and solid margins make it a standout against Philip Morris in a transforming tobacco market.
MO's Q3 results are likely to gain strength from pricing power, cost discipline and growing smoke-free momentum.
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria's Optimize & Accelerate program reinvests cost savings to fuel smoke-free growth and long-term EPS.